H. Bérard

Use of a Comprehensive Geriatric Assessment for the Management of Elderly Patients With Advanced Non–Small-Cell Lung Cancer: The Phase III Randomized ESOGIA-GFPC-GECP 08-02 Study

R. Corre, Laurent Greillier, H. Le Caer et al. · Journal of Clinical Oncology · 2016 · 401 citations

Pemetrexed and cisplatin as first-line chemotherapy for advanced non-small-cell lung cancer (NSCLC) with asymptomatic inoperable brain metastases: a multicenter phase II trial (GFPC 07-01)

Fabrice Barlési, R. Gervais, H. Léna et al. · Annals of Oncology · 2011 · 245 citations · Full text

Medicine, Gfpc 07-01, Bronchial Neoplasm +7

Bevacizumab in Patients with Nonsquamous Non–Small Cell Lung Cancer and Asymptomatic, Untreated Brain Metastases (BRAIN): A Nonrandomized, Phase II Study

Benjamin Besse, Sylvestre Le Moulec, Julien Mazières et al. · Clinical Cancer Research · 2015 · 224 citations

Feasibility and clinical impact of re-biopsy in advanced non small-cell lung cancer: A prospective multicenter study in a real-world setting (GFPC study 12-01)

C. Chouaïd, C. Dujon, Pascal Dô et al. · Lung Cancer · 2014 · 187 citations

Surgical Oncology, Real-world Setting, Health Sciences +11

Multicentre phase II study of cisplatin–etoposide chemotherapy for advanced large-cell neuroendocrine lung carcinoma: the GFPC 0302 study

J. Le Treut, M. C. Sault, H. Léna et al. · Annals of Oncology · 2013 · 173 citations · Full text

Medicine, Cisplatin–etoposide Chemotherapy, Pathology +8